Vanguard Group Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vanguard group inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vanguard Group Inc Today - Breaking & Trending Today

Royalty Pharma plc (NASDAQ:RPRX) Stake Raised by Aurora Investment Counsel

Aurora Investment Counsel boosted its holdings in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 7.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 40,558 shares of the biopharmaceutical company’s stock after acquiring an additional 2,656 shares during the quarter. […] ....

United States , Goldman Sachs Group , Norges Bank , Jpmorgan Chase Co , Exchange Commission , Morgan Stanley , Vanguard Group Inc , Aurora Investment Counsel , Royalty Pharma , Free Report , Investment Counsel , Capital Partners , Get Free Report , Royalty Pharma Daily ,

Royalty Pharma plc (NASDAQ:RPRX) Stake Raised by Aurora Investment Counsel

Aurora Investment Counsel boosted its holdings in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 7.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 40,558 shares of the biopharmaceutical company’s stock after acquiring an additional 2,656 shares during the quarter. […] ....

United States , Norges Bank , Goldman Sachs Group , Jpmorgan Chase Co , Exchange Commission , Vanguard Group Inc , Morgan Stanley , Aurora Investment Counsel , Royalty Pharma , Free Report , Investment Counsel , Capital Partners , Get Free Report , Royalty Pharma Daily ,

904 Shares in Palo Alto Networks, Inc. (NASDAQ:PANW) Acquired by Voisard Asset Management Group Inc.

Voisard Asset Management Group Inc. purchased a new position in shares of Palo Alto Networks, Inc. (NASDAQ:PANW – Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 904 shares of the network technology company’s stock, valued at approximately $267,000. A number of other large […] ....

Lee Klarich , Nir Zuk , Redburn Atlantic , Stifel Nicolaus , Insider Activity At Palo Alto Networks , Clearbridge Investments , Palo Alto Networks , Vanguard Group Inc , Palo Alto Networks Trading Down , Norges Bank , Northern Trust Corp , Jennison Associates , Voisard Asset Management Group Inc , Quarter For Palo Alto Networks , Palo Alto Networks Inc , Jpmorgan Chase Co , News Ratings For Palo Alto Networks Daily , Needham Company , Voisard Asset Management Group , Free Report , Trust Corp , Alto Networks Trading Down , Alto Networks , Get Free Report , Palo Alto , Visit Holdingschannel ,

Voisard Asset Management Group Inc. Takes Position in VIZIO Holding Corp. (NYSE:VZIO)

Voisard Asset Management Group Inc. bought a new stake in VIZIO Holding Corp. (NYSE:VZIO – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 21,715 shares of the company’s stock, valued at approximately $167,000. Several other institutional investors also recently modified […] ....

United States , Roth Mkm , Adamr Townsend , William Wei Wang , Craig Hallum , Piper Sandler , American Century Companies Inc , Securities Exchange Commission , Corient Private Wealth , Voisard Asset Management Group Inc , Exchange Commission , Vanguard Group Inc , Kennedy Capital Management , Holding Corp , Manufacturers Life Insurance Company , Voisard Asset Management Group , Free Report , Century Companies , Private Wealth , Capital Management , Wei Wang , Get Free Report ,

Investment Analysts' Recent Ratings Changes for Werewolf Therapeutics (HOWL)

A number of research firms have changed their ratings and price targets for Werewolf Therapeutics (NASDAQ: HOWL): 6/4/2024 – Werewolf Therapeutics had its “market outperform” rating reaffirmed by analysts at JMP Securities. They now have a $12.00 price target on the stock. 6/3/2024 – Werewolf Therapeutics had its “outperform” rating reaffirmed by analysts at Wedbush. […] ....

Health Sciences , Lighthouse Investment Partners , Vanguard Group Inc , News Ratings For Werewolf Therapeutics Inc Daily , Werewolf Therapeutics Inc , Financial Perspectives Inc , Werewolf Therapeutics , Therapeutics Stock Down , Get Free Report , Investment Partners , Perspectives Inc , Vanguard Group , Werewolf Therapeutics Inc Daily ,